Track PaxMedica's receivables ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for PXMD is $0 as of June 2024. That compares with $500K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside PaxMedica's historical trend and sector peers before judging valuation or financial health.
Over the past year, PXMD's receivables moved from $500K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PaxMedica's operating scale or balance-sheet position.
A receivables figure of $0 for PXMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting PXMD's receivables ($0), review year-over-year change from $500K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.